Metraipolis › archive › dc_8a33ed6311b8

Three-year follow-up of canakinumab dose extension in children with colchicine-resistant familial Mediterranean fever: PeRA-RG Experience — Europe PMC PMID:40748721

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40748721
DOI
10.1093/rheumatology/keaf403
License (as archived)
solo-consultazione
Archived
2026-11-08T03:33:07.817Z
SHA-256 of the archived text
a5159a07bc2de65f4d153d5940641676599c49c56bdaf6df08ee6408d025111b
Stable URL of this page
https://metraipolis.com/documento/dc_8a33ed6311b8

How to cite

Three-year follow-up of canakinumab dose extension in children with colchicine-resistant familial Mediterranean fever: PeRA-RG Experience — Europe PMC PMID:40748721 — Europe PMC (en), https://europepmc.org/article/MED/40748721 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a33ed6311b8 (Metraipolis archive dc_8a33ed6311b8, sha256 a5159a07bc2de65f4d153d5940641676599c49c56bdaf6df08ee6408d025111b)
BibTeX
@misc{dc8a33ed6311b8,
  title = {Three-year follow-up of canakinumab dose extension in children with colchicine-resistant familial Mediterranean fever: PeRA-RG Experience — Europe PMC PMID:40748721},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40748721},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a33ed6311b8; sha256 a5159a07bc2de65f4d153d5940641676599c49c56bdaf6df08ee6408d025111b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40748721. Agents can read the archived copy with the MCP tool read_document.